貧血治療薬の世界市場見通し2022年-2028年

◆英語タイトル:Anemia Therapeutic Drugs Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが発行した調査報告書(MMG22NV12607)◆商品コード:MMG22NV12607
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2022年11月
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の貧血治療薬市場規模と予測を収録しています。・世界の貧血治療薬市場:売上、2017年-2022年、2023年-2028年
・世界の貧血治療薬市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

世界の貧血治療薬市場は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「サプリメント」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

貧血治療薬のグローバル主要企業は、Pfizer, Inc.、 Amgen, Inc.、 Hoffmann-La Roche Ltd.、 Merck Sharp & Dohme Corp.、 Novartis AG、 Janssen Pharmaceutical、 Bayer AG、 AMAG Pharmaceuticals、 GlaxoSmithKline plc、 Akebia Therapeutics、 Vifor Pharma Management, Ltd.、 FibroGen, Inc.などです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、貧血治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の貧血治療薬市場:タイプ別、2017年-2022年、2023年-2028年
世界の貧血治療薬市場:タイプ別市場シェア、2021年
・サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤

世界の貧血治療薬市場:用途別、2017年-2022年、2023年-2028年
世界の貧血治療薬市場:用途別市場シェア、2021年
・鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌形赤血球貧血、悪性赤血球貧血

世界の貧血治療薬市場:地域・国別、2017年-2022年、2023年-2028年
世界の貧血治療薬市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における貧血治療薬のグローバル売上、2017年-2022年
・主要企業における貧血治療薬のグローバル売上シェア、2021年
・主要企業における貧血治療薬のグローバル販売量、2017年-2022年
・主要企業における貧血治療薬のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer, Inc.、 Amgen, Inc.、 Hoffmann-La Roche Ltd.、 Merck Sharp & Dohme Corp.、 Novartis AG、 Janssen Pharmaceutical、 Bayer AG、 AMAG Pharmaceuticals、 GlaxoSmithKline plc、 Akebia Therapeutics、 Vifor Pharma Management, Ltd.、 FibroGen, Inc.

*************************************************************

・調査・分析レポートの概要
貧血治療薬市場の定義
市場セグメント
世界の貧血治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の貧血治療薬市場規模
世界の貧血治療薬市場規模:2021年 VS 2028年
世界の貧血治療薬市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの貧血治療薬の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の貧血治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
貧血治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌形赤血球貧血、悪性赤血球貧血
貧血治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別貧血治療薬市場規模 2021年と2028年
地域別貧血治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Pfizer, Inc.、 Amgen, Inc.、 Hoffmann-La Roche Ltd.、 Merck Sharp & Dohme Corp.、 Novartis AG、 Janssen Pharmaceutical、 Bayer AG、 AMAG Pharmaceuticals、 GlaxoSmithKline plc、 Akebia Therapeutics、 Vifor Pharma Management, Ltd.、 FibroGen, Inc.
...

This report contains market size and forecasts of Anemia Therapeutic Drugs in Global, including the following market information:
Global Anemia Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anemia Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Supplements Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anemia Therapeutic Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anemia Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Global Anemia Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Global Anemia Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Therapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anemia Therapeutic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anemia Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anemia Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anemia Therapeutic Drugs Overall Market Size
2.1 Global Anemia Therapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Anemia Therapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anemia Therapeutic Drugs Players in Global Market
3.2 Top Global Anemia Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Anemia Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anemia Therapeutic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anemia Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anemia Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anemia Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anemia Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Anemia Therapeutic Drugs Market Size Markets, 2021 & 2028
4.1.2 Supplements
4.1.3 Antibiotics
4.1.4 Immunosuppressant
4.1.5 Bone Marrow Stimulants
4.1.6 Corticosteroids
4.1.7 Gene Therapy
4.1.8 Iron Chelating Agents
4.2 By Type – Global Anemia Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type – Global Anemia Therapeutic Drugs Revenue, 2017-2022
4.2.2 By Type – Global Anemia Therapeutic Drugs Revenue, 2023-2028
4.2.3 By Type – Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anemia Therapeutic Drugs Market Size, 2021 & 2028
5.1.2 Iron deficiency anemia
5.1.3 Thalassemia
5.1.4 Aplastic anemia
5.1.5 Hemolytic anemia
5.1.6 Sickle cell anemia
5.1.7 Pernicious anemia
5.2 By Application – Global Anemia Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application – Global Anemia Therapeutic Drugs Revenue, 2017-2022
5.2.2 By Application – Global Anemia Therapeutic Drugs Revenue, 2023-2028
5.2.3 By Application – Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Anemia Therapeutic Drugs Market Size, 2021 & 2028
6.2 By Region – Global Anemia Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region – Global Anemia Therapeutic Drugs Revenue, 2017-2022
6.2.2 By Region – Global Anemia Therapeutic Drugs Revenue, 2023-2028
6.2.3 By Region – Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Anemia Therapeutic Drugs Revenue, 2017-2028
6.3.2 US Anemia Therapeutic Drugs Market Size, 2017-2028
6.3.3 Canada Anemia Therapeutic Drugs Market Size, 2017-2028
6.3.4 Mexico Anemia Therapeutic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Anemia Therapeutic Drugs Revenue, 2017-2028
6.4.2 Germany Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.3 France Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.4 U.K. Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.5 Italy Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.6 Russia Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anemia Therapeutic Drugs Market Size, 2017-2028
6.4.8 Benelux Anemia Therapeutic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Anemia Therapeutic Drugs Revenue, 2017-2028
6.5.2 China Anemia Therapeutic Drugs Market Size, 2017-2028
6.5.3 Japan Anemia Therapeutic Drugs Market Size, 2017-2028
6.5.4 South Korea Anemia Therapeutic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anemia Therapeutic Drugs Market Size, 2017-2028
6.5.6 India Anemia Therapeutic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Anemia Therapeutic Drugs Revenue, 2017-2028
6.6.2 Brazil Anemia Therapeutic Drugs Market Size, 2017-2028
6.6.3 Argentina Anemia Therapeutic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anemia Therapeutic Drugs Revenue, 2017-2028
6.7.2 Turkey Anemia Therapeutic Drugs Market Size, 2017-2028
6.7.3 Israel Anemia Therapeutic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anemia Therapeutic Drugs Market Size, 2017-2028
6.7.5 UAE Anemia Therapeutic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Corporate Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.2.4 Amgen, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.2.5 Amgen, Inc. Key News
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Corporate Summary
7.3.2 Hoffmann-La Roche Ltd. Business Overview
7.3.3 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.3.5 Hoffmann-La Roche Ltd. Key News
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anemia Therapeutic Drugs Major Product Offerings
7.5.4 Novartis AG Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 Janssen Pharmaceutical
7.6.1 Janssen Pharmaceutical Corporate Summary
7.6.2 Janssen Pharmaceutical Business Overview
7.6.3 Janssen Pharmaceutical Anemia Therapeutic Drugs Major Product Offerings
7.6.4 Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.6.5 Janssen Pharmaceutical Key News
7.7 Bayer AG
7.7.1 Bayer AG Corporate Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Anemia Therapeutic Drugs Major Product Offerings
7.7.4 Bayer AG Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.7.5 Bayer AG Key News
7.8 AMAG Pharmaceuticals
7.8.1 AMAG Pharmaceuticals Corporate Summary
7.8.2 AMAG Pharmaceuticals Business Overview
7.8.3 AMAG Pharmaceuticals Anemia Therapeutic Drugs Major Product Offerings
7.8.4 AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.8.5 AMAG Pharmaceuticals Key News
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Corporate Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Anemia Therapeutic Drugs Major Product Offerings
7.9.4 GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline plc Key News
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Corporate Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Anemia Therapeutic Drugs Major Product Offerings
7.10.4 Akebia Therapeutics Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.10.5 Akebia Therapeutics Key News
7.11 Vifor Pharma Management, Ltd.
7.11.1 Vifor Pharma Management, Ltd. Corporate Summary
7.11.2 Vifor Pharma Management, Ltd. Business Overview
7.11.3 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Major Product Offerings
7.11.4 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.11.5 Vifor Pharma Management, Ltd. Key News
7.12 FibroGen, Inc.
7.12.1 FibroGen, Inc. Corporate Summary
7.12.2 FibroGen, Inc. Business Overview
7.12.3 FibroGen, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.12.4 FibroGen, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2017-2022)
7.12.5 FibroGen, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anemia Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Anemia Therapeutic Drugs Market Drivers in Global Market
Table 3. Anemia Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Anemia Therapeutic Drugs in Global Market
Table 5. Top Anemia Therapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anemia Therapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anemia Therapeutic Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anemia Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Anemia Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anemia Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anemia Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anemia Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anemia Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer, Inc. Corporate Summary
Table 31. Pfizer, Inc. Anemia Therapeutic Drugs Product Offerings
Table 32. Pfizer, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Amgen, Inc. Corporate Summary
Table 34. Amgen, Inc. Anemia Therapeutic Drugs Product Offerings
Table 35. Amgen, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Product Offerings
Table 38. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Sharp & Dohme Corp. Corporate Summary
Table 40. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Product Offerings
Table 41. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Anemia Therapeutic Drugs Product Offerings
Table 44. Novartis AG Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Janssen Pharmaceutical Corporate Summary
Table 46. Janssen Pharmaceutical Anemia Therapeutic Drugs Product Offerings
Table 47. Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Anemia Therapeutic Drugs Product Offerings
Table 50. Bayer AG Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 51. AMAG Pharmaceuticals Corporate Summary
Table 52. AMAG Pharmaceuticals Anemia Therapeutic Drugs Product Offerings
Table 53. AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline plc Corporate Summary
Table 55. GlaxoSmithKline plc Anemia Therapeutic Drugs Product Offerings
Table 56. GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Akebia Therapeutics Corporate Summary
Table 58. Akebia Therapeutics Anemia Therapeutic Drugs Product Offerings
Table 59. Akebia Therapeutics Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Vifor Pharma Management, Ltd. Corporate Summary
Table 61. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Product Offerings
Table 62. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 63. FibroGen, Inc. Corporate Summary
Table 64. FibroGen, Inc. Anemia Therapeutic Drugs Product Offerings
Table 65. FibroGen, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anemia Therapeutic Drugs Segment by Type in 2021
Figure 2. Anemia Therapeutic Drugs Segment by Application in 2021
Figure 3. Global Anemia Therapeutic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anemia Therapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anemia Therapeutic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anemia Therapeutic Drugs Revenue in 2021
Figure 8. By Type - Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 12. US Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 24. China Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anemia Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Akebia Therapeutics Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. FibroGen, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 貧血治療薬の世界市場見通し2022年-2028年(Anemia Therapeutic Drugs Market, Global Outlook and Forecast 2022-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆